The iPLEDGE program is a program by the U.S. Food and Drug Administration (FDA) for managing the risk of isotretinoin (also known as Accutane), a prescription medication used for the treatment of acne. Patients, their doctors and their pharmacists are required by the FDA to register and use the iPLEDGE web site in order to receive, prescribe or dispense isotretinoin. Isotretinoin carries a high risk of causing severe birth defects if taken during pregnancy (see Teratogenicity of isoretinoin) and the goals of the iPLEDGE REMS (risk evaluation and mitigation strategy) program are to prevent fetal exposure to isotretinoin and to inform prescribers, pharmacists, and patients about isotretinoin's serious risks and safe-use conditions. More information...
According to PR-model, ipledgeprogram.com is ranked 728,387th in multilingual Wikipedia, in particular this website is ranked 457,302nd in English Wikipedia.
The website is placed before vestiprim.com and after quantumuniversity.edu.in in the BestRef global ranking of the most important sources of Wikipedia.
